tirzepatide vs semaglutide compound Compared FDA says 'no clinical need'
Description
The FDA permits tirzepatide compounding because it addresses supply shortages and affordability gaps
Identical to a pre-mixed compounded vial at the same concentration
If your vial has been exposed to temperatures above 30C (86F) for more than a few hours, discard it as a safety precaution
This is more common with larger injection volumes, which is relevant if you reconstituted your 60 mg vial at a lower concentration like 5 mg/mL
On darker skin tones, it may look more purple or brown
